Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D<sub>3</sub>

<div>Comparison of the EQ-5D quality of life in the subgroups of patients with deficiency, insufficiency, and normal level of 25-hydroxycholecalciferol.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D<sub>3</sub> 

Figure 2 | Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D3 